Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $146.27 USD
Change Today +1.71 / 1.18%
Volume 1.1M
BMRN On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 5:20 PM 07/31/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Jeffrey Robert Ajer

Chief Commercial Officer and Executive Vice President, BioMarin Pharmaceutical Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 1 different industries.

53$2,677,301
As of Fiscal Year 2014

Background*

Mr. Jeffrey Robert Ajer, also known as Jeff, has been the Chief Commercial Officer of BioMarin Pharmaceutical Inc. since October 2012. Mr. Ajer has been Executive Vice President of BioMarin Pharmaceutical Inc. since December 2013 and served as its Senior Vice President since October 2012 until January 2014. He served as Vice President of Commercial Operations The Americas at BioMarin Pharmaceutical Inc. since April 2009 until September 5, 2012. He joined BioMarin in ...

Read Full Background

Corporate Headquarters*

770 Lindaro Street
San Rafael, California 94901

United States

Phone: 415-506-6700
Fax: 415-382-7889

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

BS
University of California, Irvine
MBA
University of California, Irvine

Other Affiliations*

Annual Compensation*

Salary$417,674
Total Annual Compensation$417,674

Stock Options*

Restricted Stock Awards$719,340
All Other Compensation$16,043
Exercised Options29,370
Exercised Options Value$1,521,746
Exercisable Options59,296
Exercisable Options Value$2,514,631
Unexercisable Options74,042
Unexercisable Options Value$2,086,073
Total Value of Options$6,122,450
Total Number of Options162,708

Total Compensation*

Total Annual Cash Compensation$646,217
Total Short Term Compensation$417,674
Other Long Term Compensation$735,383
Total Calculated Compensation$2,677,301
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BMRN:US $146.27 USD +1.71

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Richard F. Pops Chairman of the Board and Chief Executive Officer
Alkermes plc
$854.7K
Jeffrey M. Leiden M.D., Ph.D.Chairman, Chief Executive Officer and President
Vertex Pharmaceuticals Incorporated
$1.1M
Herve Hoppenot Chief Executive Officer, President, Director and Member of Non-Management Stock Option Committee
Incyte Corporation
$2.9M
Craig A. Wheeler Chief Executive Officer, President and Executive Director
Momenta Pharmaceuticals Inc.
$643.4K
Bruce C. Cozadd Co-Founder, Executive Chairman and Chief Executive Officer
Jazz Pharmaceuticals Public Limited Company
$830.0K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BIOMARIN PHARMACEUTICAL INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.